Re: NEWS: PLURISTEM ISSUES LETTER TO SHAREHOLDERS

patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Reply New Message

Prev Message Back To Forum Threaded View Next Message

emit

Rank: Vice President [?]

Points: 41186 [?]

Votes: 199 Score: 3.0 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: NEWS: PLURISTEM ISSUES LETTER TO SHAREHOLDERS

in response to

NEWS: PLURISTEM ISSUES LETTER TO SHAREHOLDERS

emma

posted on Jan 12, 2015 05:32PM

''The Company's patented PLX (PLacental eXpanded) cells are a drug delivery platform that releases a cocktail of therapeutic proteins in response to a host of local and systemic inflammatory and ischemic diseases.''